1f
12
9
1a
8
20
8
49
16
8
19
1
49
2
8
1b
1d
18
79
37
1d
2 29
1d
25
37
Sanjeev Vaishnavi, MD, PhD
4eAssociate Professor of Clinical Neurology
28
7f
3
60
Fellow, Institute of Aging, University of Pennsylvania, Philadelphia, PA
a1
Director, Penn Cognitive and Behavioral Neurology Fellowship, University of Pennsylvania, Philadelphia, PA
96
Clinical Director, Division of Cognitive Neurology, University of Pennsylvania, Philadelphia PA
95
Director of Clinical Research, Penn Memory Center, University of Pennsylvania, Philadelphia PA
11
Department: Neurology
4
1
b
1d
46
Contact information
40
4
3
3
1d
40
Penn Memory Center
21 2nd floor South Extension
39 3400 Civic Center Blvd
Philadelphia, PA 19104
26
21 2nd floor South Extension
39 3400 Civic Center Blvd
Philadelphia, PA 19104
35
f
18
Publications
23 a
3
2
29
23 a
Links
a4 Search PubMed for articles
d
4
b
1f
a4 Search PubMed for articles
d
13
Education:
21 7 BS 1c (Applied Biology) c
45 Georgia Institute of Technology, Atlanta, GA, 2002.
21 7 MD 15 (Medicine) c
4a Washington University in St. Louis, St. Louis, MO, 2010.
21 8 PhD 19 (Neuroscience) c
4a Washington University in St. Louis, St. Louis, MO, 2010.
c
3
3
21
21 7 BS 1c (Applied Biology) c
45 Georgia Institute of Technology, Atlanta, GA, 2002.
21 7 MD 15 (Medicine) c
4a Washington University in St. Louis, St. Louis, MO, 2010.
21 8 PhD 19 (Neuroscience) c
4a Washington University in St. Louis, St. Louis, MO, 2010.
c
1f
Post-Graduate Training
24 79 Resident in Internal Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, 2010-2011.
24 71 Resident in Neurology, Hospital of the University of Pennsylvania, Philadelphia, PA, 2011-2014.
24 88 Fellow in Cognitive and Behavioral Neurology, Hospital of the University of Pennsylvania, Philadelphia, PA, 2014-2015.
c
3
25
24 79 Resident in Internal Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, 2010-2011.
24 71 Resident in Neurology, Hospital of the University of Pennsylvania, Philadelphia, PA, 2011-2014.
24 88 Fellow in Cognitive and Behavioral Neurology, Hospital of the University of Pennsylvania, Philadelphia, PA, 2014-2015.
c
17
Certifications
28 4e Neurology, American Board of Psychiatry and Neurology, 2014.
28 6c Behavioral Neurology & Neuropsychiatry, United Council of Neurologic Subspecialties, 2016.
c
3
8d
Permanent link28 4e Neurology, American Board of Psychiatry and Neurology, 2014.
28 6c Behavioral Neurology & Neuropsychiatry, United Council of Neurologic Subspecialties, 2016.
c
2 29
21
1e
1d
24
5e
71
e 29
27
Description of Clinical Expertise
9b Dementia, Dementia Evaluation, Dementia Patient Medical Care, Memory Disorders, Memory Evaluation, Alzheimer's Disease, cognitive neurology71
Description of Research Expertise
60 Neuroimaging, resting state functional connectivity MRI, PET, aerobic glycolysise 29
23
2c1 Steven E. Arnold, MD1; Suzanne Hendrix, PhD2; Jessie Nicodemus-Johnson PhD,2; Newman Knowlton MS,2; Alison J. McManus, DNP, FNP-BC1; Monica Crane, MD3; Sanjeev N. Vaishnavi, MD, PhD4; Jeffrey M. Burns, MD5; Zoe Arvanitakis, MD, MS6; Judith A. Neugroschl, MD7; Victoria J. Williams, PhD8; Rudolph E. Tanzi, PhD9; Patrick D. Yeramian, MD, MBA10; Kent Leslie, MS11: SAFETY AND BIOLOGICAL ACTIVITY OF A FIXED-DOSE COFORMULATION OF SODIUM PHENYLBUTYRATE AND TAURURSODIOL (PB/TURSO) FOR THE TREATMENT OF ALZHEIMER’S DISEASE: RESULTS FROM THE PHASE 2A PEGASUS STUDY. The Journal of Prevention of Alzheimer's Disease 8(4): S125, Nov 2021.
12d Walker, I., Shaw, S., Vaishnavi, S., Wolk, D., Dahodwala, N., Morley, J., ... & Irwin, D. : Non-Tremor Motor Dysfunction is Associated with AD Biomarkers in Lewy Body Dementias. MOVEMENT DISORDERS 36: S285-S285, September 2021.
141 Kim B, Mikytuck B, Suh E, Gibbons GS, Van Deerlin VM, Vaishnavi SN, Spindler MA, Massimo L, Grossman M, Trojanowski JQ, Irwin DJ, Lee EB.: Tau immunotherapy is associated with glial responses in FTLD-tau. Acta Neuropathol 142(2): 243-257, Aug 2021.
1c6 Howard E, Irwin DJ, Rascovsky K, Nevler N, Shellikeri S, Tropea TF, Spindler M, Deik A, Chen-Plotkin A, Siderowf A, Dahodwala N, Weintraub D, Shaw LM, Trojanowski JQ, Vaishnavi SN, Wolk DA, Mechanic-Hamilton D, Morley JF, Duda JE, Grossman M, Cousins KA.: Cognitive Profile and Markers of AD-Type Pathology in Patients with Lewy Body Dementias. Neurology 96: e1855-e1864, Apr 2021.
217 Potorno, Nicola; Coughlin, David; Olm, Christopher A.; Wolk, David; Vaishnavi, Sanjeev; Shaw, Leslie; Dahodwala, Nabila; Morley, James; Duda, John; Deik, Andres; Spindler, Meredith; Chen-Plotkin, Alice; Lee, Edward; Trojanowski, John; McMillan, Corey T. ; Weintraub, Daniel; Grossman, Murray; Irwin, David J.: Tau pathology associates with in vivo cortical thinning in Lewy body disorders. Annals of Clinical and Translational Neurology 7(12): 2342-55, Dec 2020.
1bc Coughlin DG, Phillips JS, Roll E, Peterson C, Lobrovich R, Rascovsky K, Ungrady M, Wolk DA, Das S, Weintraub D, Lee EB, Trojanowski JQ, Shaw LM, Vaishnavi S, Siderowf A, Nasrallah IM, Irwin DJ, McMillan CT; Alzheimer’s Disease Neuroimaging Initiative.: Multimodal in vivo and postmortem assessments of tau in Lewy body disorders. Neurobiol Aging 96: 137-147, Dec 2020.
259 David G Coughlin, MD MTR; Jeffrey S Phillips, PhD; Emily Roll, BSc; Claire Peterson, BSc; Rebecca Lobrovich, MA; Katya Rascovsky, PhD; Molly Ungrady, BSc; David A Wolk, MD; Sandhitsu Das, PhD; Daniel Weintraub, MD; Edward B Lee, MD PhD; John Q Trojanowski, MD PhD; Leslie M Shaw, PhD; Sanjeev Vaishnavi, MD; Andrew Siderowf, MD MSCE; Ilya M Nasrallah, MD PhD; David J Irwin, MD MTR; Corey T McMillan, PhD: Multimodal In Vivo and Post-mortem Assessments of Tau in Lewy Body Disorders. Neurobiology of Aging 96: 137-147, Aug 2020.
b0 Vaishnavi S: New Diagnostic Insights & Challenges of Treatment. Practical Neurology Page: 3, June 2018.
1b9 Fulvio Da Re, MD; Laynie Dratch, BS; Sharon X Xie, PhD; David J Irwin, MD; Corey T McMillan, PhD; Sanjeev N Vaishnavi, MD, PhD; Carlo Ferrarese, MD, PhD; Edward B Lee, MD, PhD; Leslie M Shaw, PhD; John Q Trojanowski, MD, PhD; David A Wolk, MD; Murray Grossman, MD, EdD: Neocortical Origin and Progression of Grey Matter Atrophy In Non-Amnestic Alzheimer's Disease. Neurobiology of Aging 67 63: 75-87, March 2018 Notes: https://doi.org/10.1016/j.neurobiolaging.2017.11.008.
2c
7
1d
1f
Selected Publications
188 Walker IM, Cousins KA, Siderowf A, Duda JE, Morley JF, Dahodwala N, Tropea T, Vaishnavi S, Wolk DA, Chen-Plotkin AS, Shaw LM, Lee EB, Trojanowski JQ, Grossman M, Weintraub D, Irwin DJ.: Non-tremor motor dysfunction in Lewy body dementias is associated with AD biomarkers. Parkinsonism Relat Disord 100: 33-36, Jul 2022.2c1 Steven E. Arnold, MD1; Suzanne Hendrix, PhD2; Jessie Nicodemus-Johnson PhD,2; Newman Knowlton MS,2; Alison J. McManus, DNP, FNP-BC1; Monica Crane, MD3; Sanjeev N. Vaishnavi, MD, PhD4; Jeffrey M. Burns, MD5; Zoe Arvanitakis, MD, MS6; Judith A. Neugroschl, MD7; Victoria J. Williams, PhD8; Rudolph E. Tanzi, PhD9; Patrick D. Yeramian, MD, MBA10; Kent Leslie, MS11: SAFETY AND BIOLOGICAL ACTIVITY OF A FIXED-DOSE COFORMULATION OF SODIUM PHENYLBUTYRATE AND TAURURSODIOL (PB/TURSO) FOR THE TREATMENT OF ALZHEIMER’S DISEASE: RESULTS FROM THE PHASE 2A PEGASUS STUDY. The Journal of Prevention of Alzheimer's Disease 8(4): S125, Nov 2021.
12d Walker, I., Shaw, S., Vaishnavi, S., Wolk, D., Dahodwala, N., Morley, J., ... & Irwin, D. : Non-Tremor Motor Dysfunction is Associated with AD Biomarkers in Lewy Body Dementias. MOVEMENT DISORDERS 36: S285-S285, September 2021.
141 Kim B, Mikytuck B, Suh E, Gibbons GS, Van Deerlin VM, Vaishnavi SN, Spindler MA, Massimo L, Grossman M, Trojanowski JQ, Irwin DJ, Lee EB.: Tau immunotherapy is associated with glial responses in FTLD-tau. Acta Neuropathol 142(2): 243-257, Aug 2021.
1c6 Howard E, Irwin DJ, Rascovsky K, Nevler N, Shellikeri S, Tropea TF, Spindler M, Deik A, Chen-Plotkin A, Siderowf A, Dahodwala N, Weintraub D, Shaw LM, Trojanowski JQ, Vaishnavi SN, Wolk DA, Mechanic-Hamilton D, Morley JF, Duda JE, Grossman M, Cousins KA.: Cognitive Profile and Markers of AD-Type Pathology in Patients with Lewy Body Dementias. Neurology 96: e1855-e1864, Apr 2021.
217 Potorno, Nicola; Coughlin, David; Olm, Christopher A.; Wolk, David; Vaishnavi, Sanjeev; Shaw, Leslie; Dahodwala, Nabila; Morley, James; Duda, John; Deik, Andres; Spindler, Meredith; Chen-Plotkin, Alice; Lee, Edward; Trojanowski, John; McMillan, Corey T. ; Weintraub, Daniel; Grossman, Murray; Irwin, David J.: Tau pathology associates with in vivo cortical thinning in Lewy body disorders. Annals of Clinical and Translational Neurology 7(12): 2342-55, Dec 2020.
1bc Coughlin DG, Phillips JS, Roll E, Peterson C, Lobrovich R, Rascovsky K, Ungrady M, Wolk DA, Das S, Weintraub D, Lee EB, Trojanowski JQ, Shaw LM, Vaishnavi S, Siderowf A, Nasrallah IM, Irwin DJ, McMillan CT; Alzheimer’s Disease Neuroimaging Initiative.: Multimodal in vivo and postmortem assessments of tau in Lewy body disorders. Neurobiol Aging 96: 137-147, Dec 2020.
259 David G Coughlin, MD MTR; Jeffrey S Phillips, PhD; Emily Roll, BSc; Claire Peterson, BSc; Rebecca Lobrovich, MA; Katya Rascovsky, PhD; Molly Ungrady, BSc; David A Wolk, MD; Sandhitsu Das, PhD; Daniel Weintraub, MD; Edward B Lee, MD PhD; John Q Trojanowski, MD PhD; Leslie M Shaw, PhD; Sanjeev Vaishnavi, MD; Andrew Siderowf, MD MSCE; Ilya M Nasrallah, MD PhD; David J Irwin, MD MTR; Corey T McMillan, PhD: Multimodal In Vivo and Post-mortem Assessments of Tau in Lewy Body Disorders. Neurobiology of Aging 96: 137-147, Aug 2020.
b0 Vaishnavi S: New Diagnostic Insights & Challenges of Treatment. Practical Neurology Page: 3, June 2018.
1b9 Fulvio Da Re, MD; Laynie Dratch, BS; Sharon X Xie, PhD; David J Irwin, MD; Corey T McMillan, PhD; Sanjeev N Vaishnavi, MD, PhD; Carlo Ferrarese, MD, PhD; Edward B Lee, MD, PhD; Leslie M Shaw, PhD; John Q Trojanowski, MD, PhD; David A Wolk, MD; Murray Grossman, MD, EdD: Neocortical Origin and Progression of Grey Matter Atrophy In Non-Amnestic Alzheimer's Disease. Neurobiology of Aging 67 63: 75-87, March 2018 Notes: https://doi.org/10.1016/j.neurobiolaging.2017.11.008.
2c